tiprankstipranks
C4 Therapeutics Outlines 2025 Milestones and Achievements
PremiumCompany AnnouncementsC4 Therapeutics Outlines 2025 Milestones and Achievements
2M ago
C4 Therapeutics announces anticipated 2025 milestones
Premium
The Fly
C4 Therapeutics announces anticipated 2025 milestones
2M ago
C4 Therapeutics price target raised to $50 from $39 at Brookline
Premium
The Fly
C4 Therapeutics price target raised to $50 from $39 at Brookline
2M ago
C4 Therapeutics initiated with an Equal Weight at Stephens
PremiumThe FlyC4 Therapeutics initiated with an Equal Weight at Stephens
4M ago
C4 Therapeutics announces first patient dosed in CFT8919 clinical trial
Premium
The Fly
C4 Therapeutics announces first patient dosed in CFT8919 clinical trial
4M ago
C4 Therapeutics Advances in Protein Degradation Therapy
Premium
Company Announcements
C4 Therapeutics Advances in Protein Degradation Therapy
4M ago
C4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
PremiumThe FlyC4 Therapeutics appoints Paige Mahaney, Ph.D., as Chief Scientific Officer
5M ago
C4 Therapeutics announces next steps for CFT1946
Premium
The Fly
C4 Therapeutics announces next steps for CFT1946
6M ago
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
Premium
The Fly
C4 Therapeutics presents monotherapy data from CFT1946 Phase 1 trial
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100